Literature DB >> 1319949

Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells.

C K Chou1, L H Wang, H M Lin, C W Chi.   

Abstract

Glucocorticoids have been shown to influence the severity of hepatitis B virus-related chronic hepatitis in human. However, very little is known about the effects of glucocorticoids on hepatitis B virus replication in vitro. In this report, we used a well-differentiated human hepatoma cell line, Hep3B, transfected with hepatitis B virus complementary DNA as a model to show that a glucocorticoid analog, dexamethasone, can directly stimulate the production of HBsAg and HBeAg. Elevation of 3.5-kb pregenomic RNA and all other viral RNAs in the transfected Hep3B cells after dexamethasone treatment supports the hypothesis that glucocorticoids directly stimulate hepatitis B virus gene expression in vitro. The concentration of dexamethasone for its half-maximal stimulatory activity toward HBsAg, HBeAg and all viral transcripts was approximately 10(-8) mol/L, close to the affinity of glucocorticoid receptors to [3H]-triamcinolone acetonide in Hep3B cells (approximately 10(-8) mol/L). Specific glucocorticoid antagonist RU38486 completely blocked dexamethasone-induced HBV gene expression, suggesting that the stimulatory effect of dexamethasone was mediated through specific glucocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319949     DOI: 10.1002/hep.1840160104

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus.

Authors:  Robert Yung-Liang Wang; Chia-Ning Shen; Min-Hui Lin; David Tosh; Chiaho Shih
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases.

Authors:  Tetsu Akimoto; Toshiya Otake; Akira Tanaka; Hideaki Takahashi; Toshihiko Higashizawa; Makoto Inoue; Katsuhiko Nishino; Osamu Saito; Norio Isoda; Shigeaki Muto; Kentaro Sugano; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2010-12-18       Impact factor: 2.801

3.  A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier.

Authors:  Joong Ho Bae; Joo Hyun Sohn; Hye Soon Lee; Hye Sun Park; Yil Sik Hyun; Tae Yeob Kim; Chang Soo Eun; Yong Cheol Jeon; Dong Soo Han
Journal:  Clin Mol Hepatol       Date:  2012-06-26

4.  Association between hepatitis B virus and pancreatic cancer.

Authors:  Manal M Hassan; Donghui Li; Adel S El-Deeb; Robert A Wolff; Melissa L Bondy; Marta Davila; James L Abbruzzese
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

5.  In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.

Authors:  Y Y Lew; T I Michalak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Transcriptional and posttranscriptional control of hepatitis B virus gene expression.

Authors:  Susan L Uprichard; Stefan F Wieland; Alana Althage; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

Review 7.  The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.

Authors:  Michael H Antoni; Susan K Lutgendorf; Steven W Cole; Firdaus S Dhabhar; Sandra E Sephton; Paige Green McDonald; Michael Stefanek; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2006-03       Impact factor: 60.716

8.  A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B.

Authors:  Kazuyuki Matsumoto; Yasuhiro Miyake; Hirokazu Miyatake; Masahiro Takahara; Takayuki Imada; Satoru Yagi; Tatsuya Toyokawa; Morihito Nakatsu; Masaharu Ando; Mamoru Hirohata
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

9.  Management of hepatitis B reactivation in patients with lupus nephritis.

Authors:  Kai-Chung Tse; Susan Yung; Colin Tang; Terence Pok-Siu Yip; Tak Mao Chan
Journal:  Rheumatol Int       Date:  2009-01-22       Impact factor: 2.631

10.  Adrenalectomy to treat reactivated chronic hepatitis B infection in a patient with a steroid-secreting adrenal tumour.

Authors:  P J Smith; D Suri
Journal:  BMJ Case Rep       Date:  2011-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.